Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

September 11, 2018 12:11 ET | Source: CellAegis Devices Inc.

CellAegis meldet Abschluss der Patientenrekrutierung in der ersten nordamerikanischen Studie zu innovativer Therapie von Herzinfarkten mit autoRIC®

TORONTO, Sept. 11, 2018 (GLOBE NEWSWIRE) -- CellAegis Devices Inc. („CellAegis“ oder das „Unternehmen“), ein Unternehmen, das im Bereich für medizinische Geräte mit kommerzieller Anwendungsreife...
September 11, 2018 12:11 ET | Source: CellAegis Devices Inc.

CellAegis annonce l’achèvement de l’inscription de patients à la première étude nord-américaine pour un traitement innovant de la crise cardiaque utilisant le dispositif autoRIC®

TORONTO, 11 sept. 2018 (GLOBE NEWSWIRE) -- CellAegis Devices Inc. (« CellAegis » ou la « Société »), entreprise de dispositifs médicaux qui commercialise des solutions novatrices, non invasives,...
September 11, 2018 08:30 ET | Source: CellAegis Devices Inc.

CellAegis Announces Completion of Patient Enrollment in First North American Study for Innovative Heart Attack Therapy Using autoRIC®

TORONTO, Sept. 11, 2018 (GLOBE NEWSWIRE) -- CellAegis Devices Inc. (“CellAegis” or the “Company”), a commercial-stage medical device company advancing innovative, non-invasive, safe and...
June 14, 2018 07:00 ET | Source: CellAegis Devices Inc.

CellAegis Announces Completion of Patient Enrollment in UK Investigator Sponsored Clinical Trial using autoRIC® Device

TORONTO, June 14, 2018 (GLOBE NEWSWIRE) -- CellAegis Devices Inc. (“CellAegis” or the “Company”), a commercial-stage medical device company advancing innovative, non-invasive, safe and...
May 17, 2018 07:00 ET | Source: CellAegis Devices Inc.

CellAegis Announces Completion of Patient Enrollment in Danish Investigator Sponsored Clinical Trial Using autoRIC® Device

TORONTO, May 17, 2018 (GLOBE NEWSWIRE) -- CellAegis Devices Inc. (“CellAegis” or the “Company”), a commercial-stage medical device company advancing innovative, non-invasive, safe and cost-effective...
April 24, 2018 07:00 ET | Source: CellAegis Devices Inc.

CellAegis Announces First Distribution Agreement for autoRIC® in Europe

TORONTO, April 24, 2018 (GLOBE NEWSWIRE) -- CellAegis Devices Inc. (“CellAegis”) a commercial-stage medical device company advancing innovative, non-invasive, safe and cost-effective solutions for...
April 17, 2018 07:00 ET | Source: CellAegis Devices Inc.

CellAegis Strengthens Management Team to Support Future Growth

TORONTO, April 17, 2018 (GLOBE NEWSWIRE) -- CellAegis Devices Inc. (“CellAegis” or the “Company”), a commercial-stage medical device company advancing innovative, non-invasive, safe and...
April 10, 2018 07:00 ET | Source: CellAegis Devices Inc.

CellAegis Announces First Patients Enrolled in U.S. SHIELD Pivotal Clinical Trial

TORONTO, April 10, 2018 (GLOBE NEWSWIRE) -- CellAegis Devices Inc. (“CellAegis” or the “Company”), a commercial-stage medical device company advancing innovative, non-invasive, safe and...